Caricamento...
Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality and continues to increase. Current standard of care for patients with HCC only provides limited therapeutic benefit. Development of innovative strategies is urgently needed. Experience with immunotherapy in HCC is...
Salvato in:
| Pubblicato in: | J Clin Cell Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750497/ https://ncbi.nlm.nih.gov/pubmed/26877890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9899.1000376 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|